As of 05/20/2025, Ryman Healthcare Limited's market capitalization has reached $1.46 B. According to our data, Ryman Healthcare Limited is the 7341th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Ryman Healthcare Limited has seen its market value drop from NZ$7.55 B to NZ$2.47 B since 2020, representing a total decrease of 67.24% and an annual compound decline rate (CAGR) of 22.47%.
Date
Market Cap
Change (%)
05/20/2025
NZ$2.47 B
-23.42%
12/31/2024
NZ$3.23 B
-20.07%
12/29/2023
NZ$4.04 B
50%
12/30/2022
NZ$2.69 B
-55.77%
12/31/2021
NZ$6.09 B
-19.35%
12/31/2020
NZ$7.55 B
Company Profile
Ryman Healthcare Limited was founded in 1984 in New Zealand.
on the New Zealand Stock Exchange.
With 7700 employees, it focuses on Healthcare and aims to drive innovation in Medical Care Facilities.
Frequently Asked Questions
As of 05/20/2025, Ryman Healthcare Limited (including the parent company, if applicable) has an estimated market capitalization of $1.46 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Ryman Healthcare Limited global market capitalization ranking is approximately 7341 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.